Scarica l'app Stockscreener
2.17
11.28%
0.22
Dopo l'orario di chiusura:
2.16
-0.010
-0.46%
Precedente Chiudi:
$1.95
Aprire:
$1.93
Volume 24 ore:
99,531
Relative Volume:
0.84
Capitalizzazione di mercato:
$32.54M
Reddito:
$130.00K
Utile/perdita netta:
$-21.29M
Rapporto P/E:
-1.0976
EPS:
-1.977
Flusso di cassa netto:
$-18.29M
1 W Prestazione:
+11.86%
1M Prestazione:
+15.43%
6M Prestazione:
-10.33%
1 anno Prestazione:
-60.90%
Intervallo 1D:
$1.93
$2.2799
Intervallo di 1 settimana:
$1.8808
$2.2799
Portata 52W:
$1.22
$7.92
Serina Therapeutics Inc Stock (SER) Company Profile
Nome
Serina Therapeutics Inc
Settore
Industria
Telefono
(256) 327-9630
Indirizzo
601 GENOME WAY, HUNTSVILLE
Compare SER vs VRTX, REGN, ARGX, ALNY, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SER
Serina Therapeutics Inc
|
2.17 | 29.25M | 130.00K | -21.29M | -18.29M | -1.977 |
VRTX
Vertex Pharmaceuticals Inc
|
522.25 | 134.41B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
676.23 | 68.13B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
919.94 | 57.01B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
321.59 | 41.79B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
190.46 | 40.39B | 742.00K | -1.37B | -1.07B | -7.0731 |
Serina Therapeutics Inc Stock (SER) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-14 | Iniziato | H.C. Wainwright | Buy |
Serina Therapeutics Inc Borsa (SER) Ultime notizie
Enterprise value to EBIT forward of Serina Therapeutics, Inc. – AMEX:SER - TradingView
Serina Therapeutics (SER) Stock Forecast and Price Target 2026 $SER - MarketBeat
SER Initiated Coverage by BTIG -- Rating Set to Buy with $8.00 P - GuruFocus
Serina Therapeutics Price Target Announced at $8.00/Share by BTIG - Moomoo
BTIG Initiates Serina Therapeutics(SER.US) With Buy Rating, Announces Target Price $8 - Moomoo
BTIG initiates Serina Therapeutics stock with buy on drug delivery platform - Investing.com Canada
Gannet BioChem and Serina Therapeutics Enter Development Partnership Supporting SER-252 Program - marketscreener.com
Enterprise value to EBITDA forward of Serina Therapeutics, Inc. – AMEX:SER - TradingView
Enterprise value to revenue forward of Serina Therapeutics, Inc. – AMEX:SER - TradingView
Price to sales forward of Serina Therapeutics, Inc. – AMEX:SER - TradingView
Number of shareholders of Serina Therapeutics, Inc. – AMEX:SER - TradingView
Serina Therapeutics, Inc. Actuals & Estimates (AMEX:SER) - TradingView
SER Forecast — Price Target — Prediction for 2027 - TradingView
2BO Forecast — Price Target — Prediction for 2027 - TradingView
Serina Therapeutics, Inc. Actuals & Estimates (BOATS:SER) - TradingView
Serina Therapeutics Shareholders Approve Expanded Equity and Governance - TipRanks
Serina Therapeutics (NYSE: SER) holders back major share and equity plan increases - Stock Titan
Form 4 Serina Therapeutics Inc For: 22 June By Investing.com - Investing.com South Africa
Serina Therapeutics director Jay Venkatesan buys $1,048 in common stock By Investing.com - Investing.com Australia
Serina Therapeutics director Jay Venkatesan buys $1,048 in common stock - Investing.com
Serina (SER) director converts preferred into common and buys more stock - Stock Titan
Serina Therapeutics (SER) director boosts equity via conversions and new warrants - Stock Titan
Serina Therapeutics (SER) director receives 15,250 stock options at $1.98 - Stock Titan
Serina Therapeutics (SER) director granted 15,250 stock options at $1.98 strike - Stock Titan
Serina Therapeutics (SER) Stock Price, News & Analysis $SER - MarketBeat
Serina Therapeutics Inc (SER) Valuation: PE, PB & Fair Value Analysis - TradingKey
Why Did Serina Therapeutics Stock Rocket 37% After The Bell Today? - MSN
Serina Therapeutics Inc (SER) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Serina Therapeutics Inc (SER) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Serina Therapeutics Inc (SER) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Serina Therapeutics Inc (SER) Institutional Confidence - TradingKey
Serina Therapeutics Inc (SER) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
SER: All proposals, including director elections and share increase, were approved without stockholder questions - TradingView
SER: All eight proposals, including board elections and share increase, were approved without stockholder questions - TradingView
Serina Therapeutics Inc (SER) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Serina Therapeutics Inc (SER) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Serina Therapeutics Inc (SER) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
$Serina Therapeutics (SER.US)$ patiently waiting! - Moomoo
Insider Buying: Karen Wilson Acquires Shares of Serina Therapeutics Inc (SER) - GuruFocus
Serina Therapeutics director Karen Wilson buys $17,749 common stock By Investing.com - Investing.com India
Serina Therapeutics director Karen Wilson buys $17,749 common stock - Investing.com UK
Director Karen J. Wilson boosts Serina (SER) stake with 10,100-share purchase - Stock Titan
Serina Therapeutics Inc. (SER) Q1 2026 Earnings: Losses Wider Than Expected as Pre-Revenue Biotech Continues Clinical DevelopmentDownward Estimate Revision - newsline.com
Serina Therapeutics, Inc. Financial Disclosures & SEC Filings - TradingView
Serina Therapeutics (SER) Gains 4% as It Tests Key Resistance at $1.90BPI Bull Confirmed - newsline.com
Serina Therapeutics (SER) Tests Key Support After Modest DeclineSafe Entry Stocks - newsline.com
SER Q1 2026 Earnings: EPS Misses Estimates as Development-Focused Biotechnology Firm Continues Pipeline ProgressGuidance Accuracy Score - dars.gov.et
SER News | SERINA THERAPEUTICS INC. (NYSEARCA:SER) - ChartMill
[EFFECT] Serina Therapeutics, Inc. SEC Filing - Stock Titan
Serina Therapeutics Inc Azioni (SER) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Serina Therapeutics Inc Azioni (SER) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| WILSON KAREN J | Director |
Jun 11 '26 |
Buy |
1.75 |
5,100 |
8,900 |
5,100 |
| WILSON KAREN J | Director |
Jun 12 '26 |
Buy |
1.77 |
5,000 |
8,850 |
10,100 |
| WILSON KAREN J | Director |
May 22 '26 |
Buy |
1.93 |
10,000 |
19,300 |
20,000 |
| WILSON KAREN J | Director |
May 21 '26 |
Buy |
1.77 |
10,000 |
17,700 |
10,000 |
| Marshall Richard Peter | Director |
May 19 '26 |
Buy |
1.65 |
12,183 |
20,102 |
12,183 |
| Moreadith Randall | Chief Scientific Officer |
Mar 23 '26 |
Option Exercise |
0.06 |
6,500 |
390 |
6,500 |
| Moreadith Randall | Chief Scientific Officer |
Mar 23 '26 |
Sale |
2.86 |
6,500 |
18,568 |
0 |
| Moreadith Randall | Chief Scientific Officer |
Mar 19 '26 |
Option Exercise |
0.06 |
39,000 |
2,340 |
39,000 |
| Moreadith Randall | Chief Scientific Officer |
Mar 19 '26 |
Sale |
2.50 |
39,000 |
97,500 |
0 |
| Moreadith Randall | Chief Scientific Officer |
Feb 02 '26 |
Option Exercise |
0.06 |
6,500 |
390 |
6,500 |
1.17%
2.48%
Capitalizzazione:
|
Volume (24 ore):